Zhaoke Ophthalmology Signs Distribution Agreement with PT Ferron for BRIMOCHOL PF in Indonesia

Reuters
2025.11.06 09:46
portai
I'm PortAI, I can summarize articles.

Zhaoke Ophthalmology Limited has signed a distribution agreement with PT Ferron Par Pharmaceuticals for BRIMOCHOL™ PF in Indonesia. PT Ferron will have exclusive rights to import, promote, distribute, market, and sell the drug, which treats presbyopia. Zhaoke will receive an upfront payment and additional milestone payments based on specific achievements.

Zhaoke Ophthalmology Limited has announced that it has entered into a distribution and supply agreement with PT Ferron Par Pharmaceuticals for the commercialization of BRIMOCHOL™ PF in Indonesia. Under the agreement, PT Ferron is granted exclusive rights to import, promote, distribute, market, and sell BRIMOCHOL™ PF, an innovative drug for the treatment of presbyopia, in Indonesia. Zhaoke Ophthalmology will receive an upfront payment and is eligible for additional milestone payments based on specific achievements. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhaoke Ophthalmology Ltd. published the original content used to generate this news brief on November 06, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.